Why Compass Pathways (NASDAQ: CMPS) Could Be the Biotech Breakout of 2026

This Is the Breakthrough Moment for Evommune (NYSE: EVMN)

Why Hain Celestial (NASDAQ: HAIN) Is Suddenly Back From the Dead

Serina Therapeutics (NYSE: SER) Rallies on FDA Clearance

BioAge (NASDAQ: BIOA) Jumps as Early Data Validates Its Science

Why Outset Medical Is Back on Investors’ Radar

Federal Reclassification Could Put Pot Stocks Back on Wall Street’s Radar

Why Boring Health Insurers Might Quietly Crush the Market in 2025

Why Healthcare Stocks Still Anchor Long-Term Portfolios

PSG Equity's Move Suggests Something

The Real Innovation Isn’t Coming From Big Pharma

Where Smart Money Is Quietly Moving in Healthcare

While the Dow fell 797 points, THIS biotech stock soared 209%

Solvonis Gains 32 Percent (Top Biotech Small-Cap)

Why the Biotech Sector Is Quiet Now — and Why That Might Change Soon

Why Small-Cap Drug Developers Are Back on Wall Street’s Radar

Why Rare Disease Biotechs Could Be the Smartest Bet of the Decade

Shingles, Hep-B, and Billions in Upside – The Real Reason Sanofi Grabbed Dynavax

Tonix Pharmaceuticals Gains 96%

Trinity Biotech (NASDAQ: TRIB) Secures Major HIV Diagnostics Order – Shares Surge